While various pharmacologic effects have been reported, pregabalin essentially acts to reduce the release of excitatory neurotransmitters such as substance P and glutamate, which have been linked to the pathogenesis of bipolar disorders. The gene discussed is TAC1; the disease is bipolar disorder.